Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.28 - $1.16 $110,402 - $457,381
-394,294 Reduced 53.0%
349,591 $115,000
Q1 2024

May 15, 2024

BUY
$1.06 - $1.67 $772,410 - $1.22 Million
728,689 Added 4795.27%
743,885 $862,000
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $19,146 - $27,200
15,196 New
15,196 $25,000
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $1.75 Million - $3.19 Million
1,455,096 New
1,455,096 $1.94 Million
Q2 2022

Aug 15, 2022

BUY
$2.2 - $4.2 $61,278 - $116,986
27,854 Added 43.49%
91,898 $219,000
Q1 2022

May 16, 2022

BUY
$2.83 - $8.69 $181,244 - $556,542
64,044 New
64,044 $258,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.